ADHD in adults: take back control of your mental health

Contrary to popular belief, Attention-deficit hyperactivity disorder (ADHD) does not only affect children – many adults have ADHD too. With appropriate treatment, the sometimes-debilitating disorder can be effectively brought under control.

Around half of people with ADHD suffer from additional and associated medical or mental disordersincluding asthma, unplanned pregnancies and sexually transmitted diseases, as well as psychiatric disorders such as mood disorders, anxiety disorder, substance abuse disorders and behavioural disorders. ADHD is characterised by behavioural and cognitive symptoms such as hyperactivity.

Adults with ADHD often learn to control many of the behaviours exhibited by children with ADHD, such as fidgeting. However, they may still exhibit certain behaviours that can negatively impact their lives, their family relationships and even their careers,” says Dr. Thomas Kowallik, CEO and Country President, Novartis South Africa.

The predominant complaints seen in adult patients are trouble organising and completing necessary tasks related to either higher education or employment. Adult patients with ADHD have higher rates of academic failures and transfers, lower incomes, higher rates of job loss and turnover, high rates of car accidents, and increased rates of divorce.  It is also reported that adults with ADHD have a higher prevalence of anxiety, depression, drug abuse, and antisocial behaviours than the general population.

Fortunately, with diagnosis and appropriate treatment, adults with ADHD can overcome the destructive symptoms of the disorder. “Adult ADHD is a chronic disorder which needs chronic treatment,” says Kowallik.

Combined medication and psychosocial treatment approach are recommended as an effective treatment for most patients with ADHD.

Novartis has over 60 years in neuroscience, offering treatments for Multiple Sclerosis, Alzheimer’s, Parkinson’s, Epilepsy, and ADHD. Their research uses genetics, advanced imaging, and innovative methods to develop groundbreaking brain disorder therapies globally.